NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
Walden University NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women-Step-By-Step Guide
This guide will demonstrate how to complete the Walden University NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.
How to Research and Prepare for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
Whether one passes or fails an academic assignment such as the Walden University NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.
After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.
How to Write the Introduction for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
The introduction for the Walden University NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.
Need a high-quality paper urgently?
We can deliver within hours.
How to Write the Body for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
After the introduction, move into the main part of the NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.
Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.
How to Write the Conclusion for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.
How to Format the References List for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.
Stuck? Let Us Help You
Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease.
Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW.
Sample Answer for NRNP 6675 Week 9 Prescribing for Older Adults and Pregnant Women
Older adults often suffer from depressive disorders; severe depression is prevalent in this age group at 4% and dysthymia at 0.9% (Shang et al., 2020). Antidepressant medication and psychotherapy are the primary forms of treatment. Long-term antidepressant use may preserve well-being, lessen the risk of death, and decrease recurrence rates. However, prolonged usage may raise the risk of cardiovascular disease and osteopenia. This paper intends to propose one FDA-approved medication, one non-FDA-approved “off-label” medication, and one nonpharmacological intervention for the treatment of older persons with major depressive disorder.
Medication Recommendations
Depression in older persons is treated with pharmaceutical and non-pharmacological therapies. An FDA-approved drug called sertraline is often used to treat elderly patients with severe mental illness. Although it is usually well accepted, it should only be used under a practitioner’s supervision (Borhannejad et al., 2020). Because of its relaxing properties and appetite stimulation, mirtazapine is also used “off-label” to treat depression in older persons, which helps with insomnia and weight control (Kato et al., 2023). Lastly, a nonpharmacological method called cognitive behavioral therapy works well for treating depression by helping patients recognize and change negative thought patterns and behaviors, addressing age-related issues, and avoiding the adverse effects associated with medication (Shang et al., 2020).
Risk Assessment
A comprehensive risk assessment is crucial for administering drugs such as Sertraline (Zoloft) and Mirtazapine (Remeron) for the treatment of depression in older persons. Sertraline has advantages, including effectiveness, a favorable safety profile, and support for concomitant anxiety; nonetheless, it poses dangers such as gastrointestinal complications, hyponatremia, and potential medication interactions (Jha et al., 2022). Mirtazapine induces relaxation and stimulates hunger while presenting a reduced risk of sexual dysfunction, yet it has potential dangers of sedation, weight gain, orthostatic hypotension, and anticholinergic effects (Kato et al., 2023). CBT is a secure and practical alternative; nevertheless, it may be inaccessible and requires active patient participation (Shang et al., 2020). Clinicians must assess patient history, current medicines, and side effect profiles and include patients and families in decision-making, starting treatment with modest dosages to reduce side effects.
Clinical Practice Guidelines
Professional organizations produce clinical practice guidelines for the treatment of depression in older individuals, including evidence-based suggestions for healthcare professionals. Essential guidelines encompass those from the American Psychiatric Association, which stresses personalized treatment based on age and comorbidities; NICE, promoting a stepped-care model; and CANMAT, providing explicit recommendations for antidepressants and psychotherapy (Srifuengfung et al., 2023). Sertraline is preferred for its safety profile. However, Mirtazapine is used off-label for specific symptoms. CBT is advocated for its efficacy, especially for patients who choose non-pharmacological alternatives. These recommendations provide customized, evidence-informed treatment for elderly individuals suffering from depression.
Conclusion
Sertraline and Mirtazapine are efficacious interventions for depression in older persons. Sertraline is FDA-approved and generally well-tolerated. CBT and other nonpharmacological interventions are advantageous as well. Risk assessments are essential, and clinical guidelines stress the need for personalized, evidence-based strategies that consider patient history and preferences for optimum treatment.
References
Borhannejad, F., Shariati, B., Naderi, S., Shalbafan, M., Mortezaei, A., Sahebolzamani, E., Saeb, A., Mortazavi, S. H., Kamalzadeh, L., Aqamolaei, A., Noorbala, A. A., Namazi‐Shabestari, A., & Akhondzadeh, S. (2020). Comparison of vortioxetine and sertraline for the treatment of major depressive disorder in elderly patients: A double‐blind, randomized trial. Journal of Clinical Pharmacy and Therapeutics, 45(4), 804–811. https://doi.org/10.1111/jcpt.13177
Jha, M. K., Fatt, C. C., Minhajuddin, A., Mayes, T. L., & Trivedi, M. H. (2022). Accelerated brain aging in adults with major depressive disorder predicts poorer outcome with sertraline: findings from the EMBARC study. Biological Psychiatry Cognitive Neuroscience and Neuroimaging, 8(4), 462–470. https://doi.org/10.1016/j.bpsc.2022.09.006
Kato, M., Baba, H., Takekita, Y., Naito, M., Koshikawa, Y., Bandou, H., & Kinoshita, T. (2023). The usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study. European Journal of Clinical Pharmacology, 79(11), 1515–1524. https://doi.org/10.1007/s00228-023-03563-8
Shang, P., Cao, X., You, S., Feng, X., Li, N., & Jia, Y. (2020). Problem-solving therapy for major depressive disorders in older adults: an updated systematic review and meta-analysis of randomized controlled trials. Aging Clinical and Experimental Research, 33(6), 1465–1475. https://doi.org/10.1007/s40520-020-01672-3
Srifuengfung, M., Pennington, B. R. T., & Lenze, E. J. (2023). Optimizing treatment for older adults with depression. Therapeutic Advances in Psychopharmacology, 13. https://doi.org/10.1177/20451253231212327